|
시장보고서
상품코드
2084871
수의료 시장 : 제품별, 동물 유형별, 지역별Veterinary Healthcare Market, By Product (Therapeutics and Diagnostics), By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) |
||||||
수의료 시장은 2026년에 467억 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 853억 6,800만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 467억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 9.00% | 2033년 시장 규모 예측 : | 853억 6,800만 달러 |
수의료는 질병의 진단과 치료를 통해 효과적인 동물 헬스케어에 중점을 두고 있습니다. 이는 가축 및 야생동물의 건강에 영향을 미치는 질병의 예방, 진단, 관리, 치료는 물론, 전 세계적인 수의학적 질환(인수공통전염병 및 만성질환)의 확산 방지에 힘쓰는 의료 전문 분야입니다. 동물의 건강 문제를 치료할 때는 조기 발견이 핵심입니다.
시장 역학
인수공통전염병의 발생률 및 유병률 증가, 수의학에 대한 관심 고조, 정부 및 동물복지 단체의 적극적인 노력, 수의학에 대한 의식의 향상, 반려동물 사육 마릿수 증가, 그리고 신제품 출시 등이 전 세계 수의학 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다.
예를 들어 2019년 9월, 아부다비 농업·식품안전청(ADAFSA)은 아부다비 에미리트의 동물 질병 대책을 위해 2019-2020년도 제11차 연간 예방접종 캠페인을 시작했습니다. 이 캠페인은 해당 에미리트의 축산 농가를 강력히 지원하고, 축산 분야의 베스트 프랙티스를 장려하기 위한 ADAFSA의 노력의 일환으로 실시되었습니다.
또한 2020년 5월, Felix Pharmaceuticals Pvt. Ltd.는 세균 관련 질환 치료제로 자사의 ‘엔로플록사신 향이 첨가된 정제’가 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 수의료 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 수의료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 수의료 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 수의료 시장 : 제품별, 2021-2033년
제5장 세계의 수의료 시장 : 동물 유형별, 2021-2033년
제6장 세계의 수의료 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSAVeterinary Healthcare Market is estimated to be valued at USD 46,700 Mn in 2026 and is expected to reach USD 85,368 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 46,700 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.00% | 2033 Value Projection: | USD 85,368 Mn |
Veterinary healthcare focuses on effective animal health management by diagnosing and treating diseases. It is a medical specialty concerned with the prevention, diagnosis, control, and treatment of diseases affecting the health of domestic and wild animals, as well as to prevent transmission of veterinary diseases (zoonotic and chronic) worldwide. Early detection is key when it comes to treating health problems in animals.
Market Dynamics
Increase in incidence/prevalence of zoonosis diseases, increase in focus on veterinary healthcare, favorable initiatives by governments and animal welfare associations, increase in awareness about veterinary healthcare, rise in adoption of pets, and introduction of novel products are major factors expected to drive growth of the global veterinary healthcare market.
For instance, in September 2019, Abu Dhabi Agriculture and Food Safety Authority (ADAFSA) launched the 11th annual vaccination campaign for 2019-2020 against diseases affecting animals in the Emirate of Abu Dhabi. The campaign comes as part of ADAFSA's great support for livestock breeders in the emirate, to promote the best practices related to animal farming.
Moreover, in May 2020, Felix Pharmaceuticals Pvt. Ltd. announced that the U.S. Food and Drug Administration (FDA) approved its 'Enrofloxacin Flavored Tablets', for the treatment of diseases associated with bacteria.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global veterinary healthcare market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMerieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global veterinary healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary healthcare market.
Market Segmentation
- By Product (Revenue, USD Mn, 2021 - 2033)
- Therapeutics
- Diagnostics
- By Animal Type (Revenue, USD Mn, 2021 - 2033)
- Dogs and Cats
- Horses
- Ruminants
- Swine
- Poultry
- Other Animals
- By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Zoetis Inc.
- Virbac SA
- Vetoquinol SA
- Phibro Animal Health
- Merck & Co. Inc.
- IDEXX Laboratories
- Ceva SantE Animale
- BioMerieux SA
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in prevalence/incidence of zoonosis diseases
- High cost of veterinary healthcare services/solutions
- Increase in focus on the veterinary healthcare
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Veterinary Healthcare Market, By Product, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Veterinary Healthcare Market, By Animal Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Dogs and Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Horses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Ruminants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Swine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Poultry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Veterinary Healthcare Market, By Region, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
- Market Share Analysis, By Country, 2021-2033 (%)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
- Market Share Analysis, By Country, 2021-2033 (%)
- U.K.
- Germany
- France
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
- Market Share Analysis, By Country, 2021-2033 (%)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
- Market Share Analysis, By Country, 2021- 2033 (%)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
- Market Share Analysis, By Country, 2021- 2033 (%)
- GCC
- Israel
- Rest of the Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
- Market Share Analysis, By Country, 2021- 2033 (%)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phibro Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co. Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva SantE Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
8. Section
- Research Methodology
- About us
